The growth potential of the handheld DR market has long been confirmed by authoritative data. According to the latest report from YH Research, the global handheld DR device market size is projected to reach $160 million by 2031, with a CAGR of 17.3% from 2025 to 2031. Another authoritative institution, QYR, also holds an optimistic outlook, predicting the global market size to reach $157 million by 2031, with a CAGR of 16.61%, and annual sales in 2031 are expected to increase more than 2.5 times compared to 2024.
Such a high growth rate is driven by the resonance of multiple demands:
Rigid growth of social demand: The intensifying aging population has led to a surge in demand for chronic disease diagnosis and treatment, expanding routine screening needs for areas such as the lungs and bones. Meanwhile, frequent public health emergencies have continuously increased the demand for rapid imaging diagnostic equipment in emergency rescue scenarios.
If market demand is the 'pushing force' for the development of portable DR, then technological innovation is its 'core engine' to break through the ceiling. In the future, portable DR will iterate towards the directions of 'more intelligent, more safe, more integrated, and more connected', continuously enhancing its core competitiveness:
The integration of artificial intelligence technology will be the core upgrade direction for handheld DR. Future handheld DR devices will feature automatic focusing, intelligent image optimization, and automatic identification of lesion areas, assisting doctors in initial screening and diagnosis. This will significantly reduce the operational threshold and diagnostic pressure for primary-level doctors. For example, AI algorithms can automatically mark lung nodules, fracture sites, and other areas, bringing the accuracy of primary-level diagnosis up to the level of tertiary hospitals.
Radiation safety is a core consideration for imaging equipment, and low-dose imaging technology will become a key factor in industry competition. Currently, leading domestic enterprises have made breakthroughs, with portable DR total radiation dose stably controlled below 1 mSv/year, far lower than the 20 mSv/year limit set by the International Commission on Radiological Protection (ICRP). In the future, with optimization of material technology and imaging algorithms, handheld DR will further reduce radiation dose while maintaining high-definition imaging, expanding its application range among special populations such as children and pregnant women.
Single-function handheld DR can no longer meet the needs of complex scenarios, and multi-modal integration will become the development trend for high-end products. Domestic enterprises have taken the lead in exploring this, such as Rayson Biomedical portable multi-modal medical imaging system, which integrates ultrasound technology, X-ray technology, and vital sign monitoring technology into one unit. A single backpack can meet examination needs for multiple body parts such as bones, chest, and internal organs. It has been hailed by the industry as the 'super eyes of rescue personnel' and has demonstrated excellent value in scenarios like forest fire fighting and field rescue.
With the popularization of 5G networks, handheld DR will achieve deep integration with remote medical platforms. Images captured by primary-level doctors can be transmitted in real-time via high-speed networks to higher-level hospitals for remote expert consultations. Meanwhile, device data can be synchronized to the cloud to build patient health records, enabling full-cycle health management. This upgrade will completely break down geographic barriers to high-quality medical resources, allowing patients in remote areas to access precise diagnostic and treatment services.
In addition to routine primary healthcare settings such as township hospitals and community health service centers, handheld DR will deeply cover scenarios like home visits by general practitioners, health screenings in nursing homes, and follow-ups at rehabilitation institutions.
In the emergency field, it will serve as a core application for rapid on-site diagnosis of injuries during earthquakes, fires, and outdoor rescues, as well as large-scale screenings during public health emergencies. Typical cases include Guizhou's disease control departments using handheld DR for community rotation screenings, which effectively reduced regional incidence rates, and a non-profit organization in Pakistan completing over 8,031 screenings with the device, successfully intervening in multiple tuberculosis cases.
The portability advantage of handheld DR will also extend to industrial inspection and public safety sectors. For example, in mining and construction industries, it can be used to detect damage to equipment parts and structural safety. In customs and security inspection fields, it enables rapid check of prohibited items, expanding market space beyond medical applications.
In the global portable imaging equipment market, long dominated by European, American, and Japanese brands, domestic brands are achieving a transition from 'following' to 'leading'. Portable DR accounts for 31.58% of global production capacity, and its market share has surged from 18.89% in 2020 to 36.75% in 2024. In the future, leveraging cost-performance advantages and technological innovation capabilities, domestic brands will further expand overseas markets and capture more shares in emerging markets and mid-to-low-end markets in Europe and America.
Although the handheld DR market holds broad prospects, the industry still faces many challenges: first, the high equipment price and maintenance costs limit its popularization in some impoverished areas; second, the brand recognition in overseas markets is insufficient, and domestic brands need to strengthen channel building and brand promotion; third, the speed of technological iteration is fast, and enterprises need to continuously increase R&D investment to avoid being eliminated by the market.
For industry participants, the core of future competition will focus on three aspects: first, technological innovation capabilities, especially breakthroughs in core technologies such as AI integration and low-dose imaging; second, cost control capabilities, reducing product prices and improving cost-performance through large-scale production and supply chain optimization; third, global layout capabilities, expanding overseas channels and enhancing international brand influence.
From emergency rescue 'life-saving devices' to routine equipment in primary healthcare, and from single-mode imaging to multi-modal integration, handheld DR is riding the wave of technological innovation and market demand, entering a golden development track. With the continuous advancement of medical resource decentralization down, ongoing technological upgrades, and expanding application scenarios, handheld DR will not only reshape the competitive landscape of the medical imaging industry but also provide strong support for the balanced development of global healthcare.
For medical device professionals and investors, grasping the direction of technological innovation and keeping pace with market demand changes will allow them to seize opportunities on this high-growth track. For the general public, the popularization of handheld DR means more convenient and accurate medical services will be within reach—this is precisely the ultimate significance of medical technology development.
